Works matching IS 17568722 AND DT 2021 AND VI 14 AND IP 1
Results: 209
COVID-19 vaccines for patients with cancer: benefits likely outweigh risks.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01046-w
- By:
- Publication type:
- Article
A multicenter, randomized phase III trial of hetrombopag: a novel thrombopoietin receptor agonist for the treatment of immune thrombocytopenia.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01047-9
- By:
- Publication type:
- Article
Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Moxetumomab pasudotox in heavily pre-treated patients with relapsed/refractory hairy cell leukemia (HCL): long-term follow-up from the pivotal trial.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01004-y
- By:
- Publication type:
- Article
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Correction to: Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Outcomes with sequential FLT3-inhibitor-based therapies in patients with AML.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: MCL-1 inhibitors, fast-lane development of a new class of anti-cancer agents.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The emerging role of KDM5A in human cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01041-1
- By:
- Publication type:
- Article
The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01031-3
- By:
- Publication type:
- Article
The construction, expression, and enhanced anti-tumor activity of YM101: a bispecific antibody simultaneously targeting TGF-β and PD-L1.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01045-x
- By:
- Publication type:
- Article
CD19 CAR-T expressing PD-1/CD28 chimeric switch receptor as a salvage therapy for DLBCL patients treated with different CD19-directed CAR T-cell therapies.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Correction to: The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Correction to: Novel and emerging therapies for B cell lymphoma.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01020-y
- By:
- Publication type:
- Article
Challenges and advances in clinical applications of mesenchymal stromal cells.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01037-x
- By:
- Publication type:
- Article
FGFR-TKI resistance in cancer: current status and perspectives.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01040-2
- By:
- Publication type:
- Article
Clonal evolution in liver cancer at single-cell and single-variant resolution.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01034-0
- By:
- Publication type:
- Article
Targeting B7-H3 via chimeric antigen receptor T cells and bispecific killer cell engagers augments antitumor response of cytotoxic lymphocytes.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01024-8
- By:
- Publication type:
- Article
Antibody–drug conjugates in solid tumors: a look into novel targets.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01035-z
- By:
- Publication type:
- Article
Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01016-8
- By:
- Publication type:
- Article
Prevalence and reclassification of BRCA1 and BRCA2 variants in a large, unselected Chinese Han breast cancer cohort.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Recurrent XPO1 mutations alter pathogenesis of chronic lymphocytic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01032-2
- By:
- Publication type:
- Article
STOML2 potentiates metastasis of hepatocellular carcinoma by promoting PINK1-mediated mitophagy and regulates sensitivity to lenvatinib.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01029-3
- By:
- Publication type:
- Article
Observations on the use of Bruton’s tyrosine kinase inhibitors in SAR-CoV-2 and cancer.
- Published in:
- 2021
- By:
- Publication type:
- Letter
The integration of immune checkpoint inhibitors with VEGF targeted agents in advanced gastric and gastroesophageal adenocarcinoma: a review on the rationale and results of early phase trials.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01034-0
- By:
- Publication type:
- Article
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002).
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01033-1
- By:
- Publication type:
- Article
The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01031-3
- By:
- Publication type:
- Article
Targeting hypoxic tumor microenvironment in pancreatic cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01030-w
- By:
- Publication type:
- Article
The CXCL12gamma chemokine immobilized by heparan sulfate on stromal niche cells controls adhesion and mediates drug resistance in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01031-3
- By:
- Publication type:
- Article
Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01028-4
- By:
- Publication type:
- Article
Regulation of PD-L1 expression in the tumor microenvironment.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01027-5
- By:
- Publication type:
- Article
HOMER3 facilitates growth factor-mediated β-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01021-x
- By:
- Publication type:
- Article
How we treat mature B-cell neoplasms (indolent B-cell lymphomas).
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01018-6
- By:
- Publication type:
- Article
Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01017-7
- By:
- Publication type:
- Article
Targeting oncogenic Notch signaling with SERCA inhibitors.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01015-9
- By:
- Publication type:
- Article
NK cell-based cancer immunotherapy: from basic biology to clinical development.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01014-w
- By:
- Publication type:
- Article
Stable colony-stimulating factor 1 fusion protein treatment increases hematopoietic stem cell pool and enhances their mobilisation in mice.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-00997-w
- By:
- Publication type:
- Article
The management of metastatic GIST: current standard and investigational therapeutics.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01026-6
- By:
- Publication type:
- Article
MEK inhibitors for the treatment of non-small cell lung cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-020-01025-7
- By:
- Publication type:
- Article
The developing landscape of combinatorial therapies of immune checkpoint blockade with DNA damage repair inhibitors for the treatment of breast and ovarian cancers.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01218-8
- By:
- Publication type:
- Article
Integrated proteogenomic analysis revealed the metabolic heterogeneity in noncancerous liver tissues of patients with hepatocellular carcinoma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01195-y
- By:
- Publication type:
- Article
Bispecific antibody-activated T cells enhance NK cell-mediated antibody-dependent cellular cytotoxicity.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01216-w
- By:
- Publication type:
- Article
WDR26 and MTF2 are therapeutic targets in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01217-9
- By:
- Publication type:
- Article
GSK3-beta as a candidate therapeutic target in soft tissue sarcomas.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01215-x
- By:
- Publication type:
- Article
Therapeutic implications of cancer gene amplifications without mRNA overexpression: silence may not be golden.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01211-1
- By:
- Publication type:
- Article
Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01207-x
- By:
- Publication type:
- Article
STAT proteins: a kaleidoscope of canonical and non-canonical functions in immunity and cancer.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01214-y
- By:
- Publication type:
- Article
Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019.
- Published in:
- Journal of Hematology & Oncology, 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13045-021-01213-z
- By:
- Publication type:
- Article